Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C192897> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- NCIT_C192897 IAO_0000115 "A regimen consisting of bevacizumab and mirvetuximab soravtansine that can be used for the treatment of ovarian cancer,fallopian tube and primary peritoneal cancer." @default.
- NCIT_C192897 NCIT_NHC0 "C192897" @default.
- NCIT_C192897 NCIT_P106 "Therapeutic or Preventive Procedure" @default.
- NCIT_C192897 NCIT_P108 "Bevacizumab/Mirvetuximab Soravtansine Regimen" @default.
- NCIT_C192897 NCIT_R123 NCIT_C102566 @default.
- NCIT_C192897 NCIT_R123 NCIT_C129821 @default.
- NCIT_C192897 NCIT_R123 NCIT_C129822 @default.
- NCIT_C192897 NCIT_R123 NCIT_C129823 @default.
- NCIT_C192897 NCIT_R123 NCIT_C1512 @default.
- NCIT_C192897 NCIT_R123 NCIT_C163758 @default.
- NCIT_C192897 NCIT_R123 NCIT_C1742 @default.
- NCIT_C192897 NCIT_R123 NCIT_C1908 @default.
- NCIT_C192897 NCIT_R123 NCIT_C1909 @default.
- NCIT_C192897 NCIT_R123 NCIT_C198860 @default.
- NCIT_C192897 NCIT_R123 NCIT_C200086 @default.
- NCIT_C192897 NCIT_R123 NCIT_C200114 @default.
- NCIT_C192897 NCIT_R123 NCIT_C2039 @default.
- NCIT_C192897 NCIT_R123 NCIT_C20401 @default.
- NCIT_C192897 NCIT_R123 NCIT_C2496 @default.
- NCIT_C192897 NCIT_R123 NCIT_C274 @default.
- NCIT_C192897 NCIT_R123 NCIT_C307 @default.
- NCIT_C192897 NCIT_R123 NCIT_C308 @default.
- NCIT_C192897 normalizedInformationContent "100" @default.
- NCIT_C192897 referenceCount "1" @default.
- NCIT_C192897 hasExactSynonym "Avastin/Elahere" @default.
- NCIT_C192897 hasExactSynonym "Bevacizumab-Mirvetuximab Soravtansine" @default.
- NCIT_C192897 hasExactSynonym "Bevacizumab/Mirvetuximab Soravtansine Regimen" @default.
- NCIT_C192897 hasExactSynonym "Bevacizumab/Mirvetuximab Soravtansine" @default.
- NCIT_C192897 hasExactSynonym "Bevacizumab/Mirvetuximab Soravtansine-gynx" @default.
- NCIT_C192897 hasExactSynonym "Elahere/Avastin" @default.
- NCIT_C192897 hasExactSynonym "Mirvetuximab Soravtansine-Bevacizumab" @default.
- NCIT_C192897 hasExactSynonym "Mirvetuximab Soravtansine-gynx/Bevacizumab" @default.
- NCIT_C192897 hasExactSynonym "Mirvetuximab Soravtansine/Bevacizumab Regimen" @default.
- NCIT_C192897 hasExactSynonym "Mirvetuximab Soravtansine/Bevacizumab" @default.
- NCIT_C192897 inSubset NCIT_C160950 @default.
- NCIT_C192897 inSubset NCIT_C160952 @default.
- NCIT_C192897 type Class @default.
- NCIT_C192897 isDefinedBy ncit.owl @default.
- NCIT_C192897 label "Bevacizumab/Mirvetuximab Soravtansine Regimen" @default.
- NCIT_C192897 subClassOf B00101d76b5c324bd096f34b3394c4dc6 @default.
- NCIT_C192897 subClassOf B3ea1d0cc75673763adfa13da03cb6774 @default.
- NCIT_C192897 subClassOf B617f6e2fbaf8af60adaffe7c805fa6cd @default.
- NCIT_C192897 subClassOf Bfe630ad595b50e1df60be7a7a2ff319e @default.
- NCIT_C192897 subClassOf NCIT_C12218 @default.
- NCIT_C192897 subClassOf NCIT_C159900 @default.
- NCIT_C192897 subClassOf NCIT_C159901 @default.
- NCIT_C192897 subClassOf NCIT_C192897 @default.
- NCIT_C192897 subClassOf NCIT_C62634 @default.
- NCIT_C192897 subClassOf NCIT_C63522 @default.